Breast cancer is a sex steroid hormone-dependent malignant neoplasia. The role of oestradiol in this malignancy has been well documented; however, the involvement of androgens has remained controversial. To determine the role of nonphenolic androgen metabolites in human breast cancer, we studied the metabolism of [
Introduction
The key role of oestrogens for both the initiation and progression of most breast cancer tumours has been well established (Kirschner 1979 , Nicholson et al. 1988 , Pike & Spicer 1991 , Pike et al. 1993 , Musgrove & Sutherland 1994 , Pasqualini & Chetrite 1996 , Girdler & Brotherick 2000 ; however, the precise involvement of other sex steroid hormones on this malignancy has remained a controversial issue. Evidence has accumulated indicating that androgens may act as either stimulating or inhibiting hormonal agents in breast cancer, though the mechanisms by which they exert these effects have not yet been elucidated. Indeed, numerous studies in animal models have shown that androgens, at physiological concentrations, stimulate growth in mammary cancer (Smith & King 1972 , Liao et al. 1998 , Xie et al. 1999 , Liao & Dickson 2002 , Somboonporn & Davis 2004 , while other reports have indicated that their administration results in tumour regression of chemically and hormone-induced breast cancers (Costlow et al. 1976 , Zhou et al. 2000 . The inhibitory capability of androgens in human breast cancer has been documented in experimental and clinical studies (Poulin et al. 1988 , Jørgensen et al. 1997 , Szelei et al. 1997 , Adams 1998 , Labrie et al. 2003 , Greeve et al. 2004 , Somboonporn & Davis 2004 , though the absence of anti-proliferative effects on several human breast cancer cells has also been reported (Roy et al. 1992) . Interestingly, several studies have shown that androgens may exhibit an initial inhibitory effect that shift to a late stimulatory effect on human breast cancer cell proliferation (Lippman et al. 1976 , Hackenberg et al. 1993 , Labrie et al. 1998 , Aspinall et al. 2004 .
The presence of androgens in normal and malignant breast tissue, as well as their enzyme-mediated conversion to oestrogens, has been well documented in pre-and postmenopausal women (reviewed in Pasqualini & Chetrite (1996) ). Although the aromatisation of androgens in breast cancer cells has remained controversial, low, but reproducible aromatase activity has been detected in MCF-7 cells (Sonne-Hansen & Lykkesfeldt 2005) . To avoid oestrogen formation, several aromatase inhibitors have been widely used in therapeutic schemes in breast cancer (Coombes et al. 1987 , Santen et al. 1990 , Demers 1994 , Goss 1999 , Ragaz 1999 , Sasano et al. 1999 , although the oestrogen-like effects of androgens are not completely suppressed by this treatment (Brodie et al. 1977 , Brodie & Longcope 1980 , Coombes et al. 1984 , Wing et al. 1985 , Lippman 1998 , Buzdar 2002 , Lønning 2004 , Brueggemeier et al. 2005 . These observations raise the important question as to whether androgens are locally bioconverted to non-phenolic metabolites with intrinsic oestrogenic activities. Androgen-metabolising enzymes, other than aromatase, have been identified and characterised in human breast cancer tissue and cells (Bonney et al. 1983 , Sasano et al. 1996 , Gingras et al. 1999 , and an overexpression of 5a-steroid reductase type-1 gene has been reported in human breast cancer tumours (Suzuki et al. 2001) .
To determine whether androgens are bioconverted to A-ring-reduced derivatives with intrinsic oestrogen-agonistic potency in breast cancer, we studied the metabolism of [ 14 C]-labelled testosterone and D
4
A in oestrogen-dependent (MCF-7) and non-oestrogen-dependent (MDA-MB 231) human breast cancer cells. Non-oestrogen-dependent human uterine cervical cancer (HeLa) cells and yeast cells served as experimental controls. The results disclose a distinctive androgen-metabolic pathway in MCF-7 cells, characterised by overexpression and enhanced activities of the androgenmetabolising enzymes, resulting in a large formation of 3a,5a-diol and 3b,5a-diol. In subsequent studies, the oestrogen-like activity of both the diols, was assessed by their binding affinity to the a and b subtypes of the human oestrogen receptor (hER), their capability to activate oestrogen response elements of a reporter gene in the construct assay employed, and their ability to induce cell proliferation in MCF-7 cells.
Further interest for the conduction of this study stemmed from the recent observations in our laboratory (Lemus et al. 2000 , Larrea et al. 2001 , García-Becerra et al. 2002 , demonstrating that the A-ring tetrahydro-reduced metabolites of norethisterone, levonorgestrel and gestodene, possess oestrogen-agonistic activities, suggesting that they could be involved in the activation of breast cancer cell proliferation induced by high doses of synthetic contraceptive progestins derived from 19-nor testosterone, as it has been previously reported (Catherino et al. 1993 , Schoonen et al. 1995a ,1995b . 
Materials and Methods

Steroids and chemicals
Cell lines and culture
Human breast cancer cells lines MCF-7 (hER dependent) and MDA-MB 231 (hER independent), obtained from Dr A Zentella (Instituto Nacional de Ciencias Médicas y Nutrición S. Zubirán, Mexico City, México) were cultured in T-45 flasks with phenol red Dulbecco's modified Eagle mediumhigh glucose (DMEM-HG) containing L-glutamine and supplemented with 5% FBS, 100 U/ml penicillin, 100 mg/ml streptomycin and 10 nM oestradiol, in a 95% air:5% CO 2 atmosphere, at 37 8C. Human uterine cervical cancer (HeLa) cells, kindly supplied by Dr A J Cooney (Baylor College of Medicine, Houston, TX, USA), were cultured in T-45 flasks with phenol red DMEM-HG containing L-glutamine and supplemented with 10% stripped FBS, 100 U/ml penicillin and 100 mg/ml streptomycin in a 95% air:5% CO 2 atmosphere, at 37 8C. Yeast cells (Saccharomyces cerevisiae), were cultured in gold medium at 32 8C by continuous shaking using air as the gas phase.
Androgen metabolism
To assess the in situ conversion of androgens to A-ringreduced derivatives in human breast cancer, the metabolism of [ , at 37 8C, in a 95% air:5% CO 2 atmosphere, using the increasing substrate concentrations (1-10 mM) of either
A, for different time periods (30 min-48 h), at pH 7$4 and 5$2, in the absence or presence of 1 mM finasteride (Merck). All incubations were carried out in phenol red-free and oestradiol-free, supplemented DMEM-HG culture medium. To determine the activities of the two types of 5a-steroid reductases (Russell & Wilson 1994) , incubations were carried out at pH 7$4 and 5$2. In addition, similar incubations were done using cell homogenates at pH 7$4 and 5$2, in the presence of 2$5 mM NADPH. Final incubation volume was 3 ml. Cell-free and boiled inactivated cell incubations, carried out under identical conditions, were used as negative controls. Protein content was determined by a protein-dye-binding method (Bradford 1976 ) using BSA as standard. At the end of the incubation period, the reaction was stopped by the addition of ethyl acetate, and radiolabelled steroids were extracted (4!) using three volumes of watersaturated ethyl acetate. The organic extracts were partitioned between petroleum ether and 10% aqueous methanol, and 2$5 mg each of the following steroid carriers were added to the methanolic extracts: testosterone (T), 17b-hydroxy-4-androstene-3-one; 5a-dihydrotestosterone (DHT), 17b-hydroxy-5a-androstane-3-one; 3a,5a-androstanediol (3a,5a-diol), 5a-androstane-3a,17b-diol; 3b,5a-androstanediol (3b,5a-diol), 5a-androstane-3b,17b-diol; androstenedione (D 4 A) 4-androstene-3,17-dione and 5a-dihydroandrostanedione (5a-A), 5a-androstane-3,17-dione. The identification and radiochemical purity of androgen metabolites were established by a reverse isotope dilution technique, which included identical behaviour to that of the steroid carriers in two different thin layer chromatographic systems (chloroform:acetone, 9:1 and benzene:ethyl acetate, 2:1) and recrystallisations to obtain a constant sp. act. Radioactive labelled [ 14 C] metabolites were located on chromatographic plates using a Packard instant imager (Downers Grove, IL, USA). Radioactivity was otherwise determined in a Packard Tri-Carb liquid scintillation spectrometer model 1900 TR (Packard Instrument Company, Inc.), using toluene containing 4 g/l 2,5-diphenyloxazole (PPO) and 100 mg/l dimethyl 1,4-bis-2-(4-methyl-5-phenyloxazolyl)-benzene as the counting solution. The counting efficiency for [ 14 C] was 86% and [ 3 H] was 65% and quenching was corrected in all samples by external standardisation. Nonradioactive steroid carriers were detected on chromatograms using the p-anisaldehyde-sulphuric/acetic acids reagent. The formation rates of the metabolic conversion products of androgens are expressed as pmol/mg of protein per hour. The enzyme-mediated bioconversion of androgens in MCF-7, MDA-MB 231 and HeLa cells is expressed as the percent conversion of testosterone and D
4
A to their non-phenolic metabolites, as a function of time.
Steroid enzyme expression
The gene expression of androgen-metabolising enzymes in MCF-7 and MDA-MB 231 cells was studied by RT-PCR. Total RNA from the cells (6!10 6 ) was extracted using TRIzol reagent and an aliquot (5 mg) from each sample was subjected to reverse transcription using a Superscript first strand cDNA synthesis kit (Invitrogen), according to the manufacturer's protocol. Semi-quantitative PCR was performed using 2$5 U Platinum Taq DNA polymerase, 4 mM MgCl 2 , 0$4 mM dNTPs and 4 mM of each gene-specific steroid enzyme primer, using GAPDH as an internal standard. All PCRs were done up to 30 cycles, each cycle consisting of 5 min at 94 8C, 30 s at 52-64 8C and 7 min at 72 8C. PCR products were electrophoresed on ethidium bromidecontaining 1$2% agarose gels, and the bands were subjected to scanning densitometry using a gel analyzer (Kodak). Results are given as relative density (mRNA enzyme/mRNA GAPDH). Gene-specific primer sequences were as follows: human steroid 5a-reductase type-1 (SRD5A1; NM_001047): 5 0 TGGGAGGAGGAAAGCCTATG (sense), 5 0 GCCACA-CCACTCCATGATTTC (anti-sense); human steroid 5a-reductase type-2 (SRD5A2; NM_000348):
0 CACCCATGGTTCTT CTCGA (anti-sense) and human GAPDH: 5 0 TTCGCT CTCTGCTCCTCCTG (sense), 5 0 ACCCGTTGACTCC GACCTTC (anti-sense).
Each PCR was run three times in duplicate according to the manufacturer's recommendations and default settings.
Plasmid constructs
The expression vectors for human ERa and ERb genes (plasmid of the cytomegalovirus (pCMV) 5 -hERa and pCMV 5 -hERb) containing the coding sequence of hERa and hERb were kindly provided by Dr A J Cooney. The oestrogen responsive reporter plasmid containing a fragment of the vitellogenin A2 gene promoter (positions K331 to K87) upstream of the adenovirus E1b promoter region fused to the chloramphenicol acetyltransferase (CAT) gene (EREE1b-CAT) was constructed according to the method described by Smith et al. (1993) .
Transfections
The HeLa cells were plated the day before transfections in a six-well plate at a density of 3!10 5 cells/well in phenol redfree DMEM-HG supplemented with 5% stripped FBS, 100 U/ml penicillin and 100 mg/ml streptomycin. Cells were maintained in a 95% air:5% CO 2 atmosphere at 37 8C. The next day, cells were visualised in a microscope to assure that the cell density was 30-50% confluent. Transfections were performed in triplicate using SuperFect (Qiagen), according to the manufacturer's protocol. Briefly, serumfree media (100 ml) was aliquoted and DNA added (1 mg reporter gene plasmid and 0$025 mg of either hERa or hERb gene expression vectors) and vortexed. SuperFect reagent (10 ml) was added and vortexed for additional 10 s. Following incubation at room temperature for 5-10 min, 600 ml supplemented DMEM-HG was added to each tube. The medium containing the transfection complexes was added to the cell monolayer previously rinsed with PBS. The plates were incubated for 3 h in a 95% air:5% CO 2 atmosphere, at 37 8C. After incubation, the plates were rinsed with PBS and 3 ml supplemented DMEM-HG was added to each well.
Binding affinity of androgen metabolites to hER
After transfection, cells were harvested by centrifugation and washed with TEDLM buffer (20 mM Tris-HCl, pH 7$4 at 4 8C, 1$5 mM EDTA, 0$25 mM dithiotreitol, 10 mg/ml leupeptine and 10 mM sodium molibdate) in a ratio (w/v) 1:6. The cytosolic fraction was obtained by vortexing the cells with glass beads in TEDLM buffer followed by centrifugation at 180 000 g, for 1 h, at 2 8C, in an SW 50$1 rotor (Beckman Instruments, Palo Alto, CA, USA). To assess the binding affinity of 3a,5a-diol and 3b,5a-diol to hERa and hERb, cytosol aliquots (0$5 mg protein/ml) of the co-transfected HeLa cells were incubated with 1 nM [ 3 H]-E 2 at 4 8C for 18 h, in the absence or presence of increasing concentrations (1-1000 nM) of radioinert oestradiol, 3a,5a-diol and 3b,5a-diol. Bound and free steroid fractions were separated by the addition of 800 ml Dextran-coated charcoal suspension (250 mg Norit-A and 25 mg Dextran T-70) in 100 ml TEDLM buffer and incubated for 10 min at 4 8C. Following centrifugation at 800 g, at 4 8C, for 15 min, aliquots (200 ml) of the supernatants were submitted to radioactive counting. Radioactive content in the aqueous samples was determined using Insta-Gel Plus (Packard, Downers Grove, IL, USA) as counting solution. The results are expressed as the relative binding affinities (RBA) and the inhibition constants (K i ) of steroid competitors, as described by Reel et al. (1979) and Cheng & Prusoff (1973) respectively.
Oestrogen-agonistic effect of androgen metabolites
The oestrogen-agonistic actions of androgen metabolites were assessed in transiently co-transfected HeLa cells with the mammalian expression vector for hERa or hERb genes and its cognate reporter vector ERE-E1b-CAT, using oestradiol as control. Twenty-four hours after co-transfection, cells were incubated in a complete medium containing the increasing concentrations (1!10 K12 -1!10 K6 M) of 3a,5a-diol, 3b,5a-diol and oestradiol, using dimethyl sulfoxide as the steroid vehicle. Incubations were carried out in the absence or presence of 1!10 K7 M ICI-182 780 (Zeneca Farma, Mexico City, Mexico), a potent steroidal antioestrogen, in a 95% air:5% CO 2 atmosphere, for 24 h at 37 8C. At the end of the incubation period, cells were harvested and submitted to the liquid CAT assay as previously described (Lemus et al. 2000 , García-Becerra et al. 2002 . Results of the transactivation studies are expressed as the effective concentration values (EC 50 ) of 3a,5a-diol, 3b,5a-diol and oestradiol, obtained by a non-linear regression analysis, using a scientific graphic software (Origin 6$1; OriginLab, Northampton, MA, USA).
Cell proliferation studies
The MCF-7 cells were cultured in DMEM without phenol red, containing heat-inactivated FBS (5% v/v), 2 mM L-glutamine, 100 U/ml penicillin and 100 mg/ml streptomycin. Cells were incubated in six-well plates at a density of 1!10 6 cell/well in a 5% CO 2 humidified incubator at 37 8C. After 24 h, the medium was replaced with DMEM containing dextran/charcoalstripped FBS (2$5%) and oestradiol (1!10 K9 M) or 3a,5a-diol or 3b, 5a-diol (1!10 K7 M) dissolved in ethanol and incubated for 48 h. Cells were quantified and scored to measure proliferation rate (Lopez-Diazguerrero et al. 2006) . [ 3 H]-Thymidine (1 mCi) was added to the culture medium and incubated for additional 24 h. Cells were washed with PBS and fixed for 15 min with 500 ml of 95% methanol in PBS. Subsequently, cells were gently washed twice with PBS and 500 ml 0$2 M NaOH were added. Alkaline extracts were submitted to radioactivity counting. Results were expressed as the cell proliferation (%) induced by diols, using oestradiol and vehicle as controls.
Statistical analysis
The comparisons of experimental groups with controls in metabolic studies were done by one-way ANOVA and statistical differences between groups were established by Student's t-test, using the SigmaStat statistical software (Jandel Corporation, San Rafael, CA, USA). Group differences were considered significant when P!0$001 was reached (twotailed test). Variance analysis of enzyme expression and cell proliferation studies was performed using the statistical software Statistical Package for the Social Sciences (SPSS, Inc., Chicago, IL, USA) and group differences were considered significant when P!0$05 was reached.
Results
Androgen metabolism in MCF-7 and MDA-MB 231 cells
After partition of the MCF-7 cells organic extracts, 96% of the incubated radioactive material was recovered in the methanolic fraction. When aliquots of methanolic extract from [ 14 C]-T incubations were submitted to thin-layer chromatography, four radioactive zones were detected, as shown in Fig. 1A . Zone 1 (R F Z0$22), representing the major metabolic conversion products of [ 14 C]-T, had a chromatographic behaviour identical to those of the 3a,5a-diol and 3b,5a-diol carriers. After elution, representative aliquots were separately mixed with additional radioinert 3a,5a-diol and 3b,5a-diol and recrystallised to constant sp. act. (Table 1) . Formation of 3a,5a-diol was higher than that of its 3b isomer. Zone 2 (R F Z0$34) was identified as unchanged [ A, were identified as diols and testosterone respectively. Their radiochemical purity is shown in Table 1 . Zone 3 (R F Z 0$46) had a chromatographic behaviour identical to that of DHT. Zone 5 (R F Z0$67) had a chromatographic mobility corresponding to that of 5a-A and zone 4 (R F Z0$55) corresponded to unconverted [ biotransformation to testosterone and 5a-reduced metabolites, as depicted in Fig. 1F .
The metabolism of testosterone in MCF-7, MDA-MB 231 and HeLa cells, as a function of substrate concentration is shown in Fig. 2 . Incubations were carried out at 37 8C, for 2 h, at pH 7$4 and 5$2. The metabolic pattern of [
14 C]-T in MCF-7 cells ( Fig. 2A and B) was similar in incubations carried out at both pH levels, with the distinctive feature of a large formation of diols, noticed even at the lowest substrate concentration. Interestingly, a significantly larger formation of diols occurred in incubations at pH 7$4 as compared with those at pH 5$2. In contrast, very little, if any, diol formation was noticed in incubations of MDA-MB 231 and HeLa cells with [ 14 C]-T, even at the highest substrate concentration studied (Fig. 2C-F) . A large formation of D 4 A at both pH levels was observed in HeLa cells and a limited bioconversion of testosterone to DHT. When MCF-7 cell homogenates, added with NADPH, were incubated with [ 14 C]-T for 2 h, the percent conversion of testosterone to diols was significantly higher at pH 7$4 (63$2%), as compared with those at pH 5$2 (37$4%).
The metabolism of [ A in MCF-7 cells was similar in incubations carried out at both pH levels ( Fig. 3A and B) , and was characterised by a simultaneous large formation of testosterone and 5a-reduced metabolites (5a-A, diols and DHT). A moderately large formation of 5a-reduced [ HeLa cells was characterised by very little formation of testosterone, noticed only at the highest substrate concentration used, and a relatively higher formation of 5a-A, particularly in incubations undertaken at pH 7$4 ( Fig. 3C-F) .
The enzyme-mediated formation of 5a-reduced metabolites of testosterone in MCF-7, MDA-MB 231 and HeLa cells, as a function of time, is depicted in Fig. 4 . Cells were incubated with 2 mM [ 14 C]-T at 37 8C, pH 7$4, at different time periods. The results demonstrated that radiolabelled testosterone incubated with MCF-7 cells was extensively bioconverted to diols, presumably through its prior conversion to DHT. Indeed, the maximal accumulation of DHT occurred at 30 min of incubation with a subsequent decline and a concomitant time-dependent increase on the formation of diols (Fig. 4A) . At 48 h incubation, 48$3% of the [ 14 C]-labelled testosterone was bioconverted to diols. According to recrystallisation data, the formation of 3a,5a-diol and 3b,5a-diol occurred in a ratio of 2:1. In sharp contrast, the absence of formation of diols was observed in incubations of MDA-MB 231 and HeLa cells with [ 14 C]-T, with very small and delayed formation of DHT ( Fig. 4B and  C) . The effect of a 5a-steroid reductases inhibitor on the metabolism of androgens in MCF-7 cells is shown in A, at 37 8C, for 48 h, at pH 7$4, in the absence or presence of 1 mM finasteride. As it can be seen, the addition of finasteride resulted in a significant diminution of the bioconversion of radiolabelled testosterone and D 4 A to their corresponding 5a-dihydro metabolites and in an abolishment of diols formation (Fig. 5, inserts) . In all incubations with MCF-7, MDA-MB 231 and HeLa cells, neither oestradiol nor oestrone was detected as conversion products of 
Enzymes gene expression profile in MCF-7 and MDA-MB 231 cells
The results from androgen-metabolising enzymes gene expression in the two cell lines studied, as determined by semi-quantitative RT-PCR assays, are shown in Fig. 6 . The level of expression of SRD5A1 was significantly (P!0$05) higher in MCF-7 cells, as compared with MDA-MB 231 cells. In contrast, the expression of SRD5A2 in both cell lines did not exhibit differences. Interestingly, the expression of SRD5A1 was significantly higher (P!0$01) in both cell lines, as compared with SRD5A2. The expression level of AKR1C1 and AKR1C2 was similar in MCF-7 and MDA-MB 231 cells, though the expression of AKR1C1 was significantly higher (P!0$001) than that of AKR1C2 in both cell lines studied.
Binding affinity of androstanediols to hER
The effect of increasing concentrations of non-radioactive diols upon the [ ]-E 2 bound to hER in the absence of steroid competitors was set at 100% in this radioligand competitive assay. Even though both diols were competitors for hERa, the 3b,5a-diol exhibited higher affinity (RBAZ 1$9%; K i Z3$25 nM) than its 3a-isomer (RBAZ0$009%; K i Z625 nM). The 3b,5a-diol was more efficient competitor for the b subtype of hER (RBAZ0$92%; K i Z6$5 nM) than 3a,5a-diol (RBAZ0$006%; K i Z950 nM). The 3b,5a-diol and to a lesser extent its 3a-isomer, bound to both subtypes Incubations were carried out for 2 h at 37 8C, using increasing substrate concentrations, at two different pH levels. The 3a,5a-and 3b,5a-androstanediols (diols) were identified as the major metabolic conversion products in MCF-7 cells, even at the lowest substrate concentration. Diol formation was higher in incubations at pH 7$4 (A), as compared with those at pH 5$2 (B). Androstenedione (D 4 A) and 5a-dihydrotestosterone (DHT), in a smaller proportion, were also identified as testosterone metabolites at both pH levels (A) and (B). On the contrary, very little formation of metabolites occurred in incubations of [ 14 C]-testosterone with MDA-MB 231 cells (C) and (D), whereas a large bioconversion of [ of hER, in a similar manner to that of oestradiol used as positive control, though with lower affinity.
Oestrogen-like transactivation effect of androstanediols
The transactivation effect of 3a,5a-diol and its 3b-isomer in the co-transfected cell expression system employed is shown in Fig. 8 . Both diols induced the transactivation of hERamediated CAT activity, in a dose-response manner, similar to that induced by oestradiol, yet with lower potency (Fig. 8A  and B) . At steroid concentrations that induced the highest CAT gene transactivation, the oestrogen-like effect of 3b,5a-diol (1!10 K7 M) was 100-fold less potent than oestradiol (1!10 K9 M), whereas 3a,5a-diol (1!10 K6 M) was tenfold less potent than 3b,5a-diol as depicted in Fig. 8A and B. The effect of both diols on hERb-mediated reporter gene transcription, as compared to that of oestradiol, is shown in Fig. 8C and D. The highest oestrogen-agonistic transactivation effect of 3b,5a-diol (1!10 K7 M) was 100-fold less potent than oestradiol (1!10 K9 M), while 3a,5a-diol induced transactivation only at the highest concentration employed (1!10 K6 M). The comparative potencies of both diols and oestradiol, to induce CAT gene transactivation mediated by the subtypes a and b of hER, as judged by their EC 50 , are depicted in Table 2 .
The addition of ICI-182 780 to cell culture incubations, significantly inhibited (P!0$001) the ability of 3b,5a-diol, 3a,5a-diol and oestradiol to stimulate hERa-and hERbmediated transcriptional activities as shown in Fig. 9 . These results ensured the stimulatory activity of diols via both subtypes of hER.
Effect of diols in cell proliferation
To assess the effect of 3a,5a-and 3b,5a-diols on cell proliferation in MCF-7 cells, a set of experiments using [ A) to non-phenolic metabolites in MCF-7, MDA-MB 231 and HeLa cells, as a function of substrate concentration. Incubations were carried out for 2 h at 37 8C, using increasing substrate concentrations, at two different pH levels. Testosterone (T) and 3a,5a-and 3b,5a-androstanediols (diols) were identified as the major metabolic conversion products in MCF-7 cells (A) and (B). A larger formation of T and 5a-reduced D in MCF-7 cells significantly (150%) as compared with vehicle, in a similar fashion to that exerted by 1!10 K9 M oestradiol (140%). Treatment with 1!10 K7 M 3a,5a-diol also increased cell proliferation (50%) as compared with vehicle in MCF-7 cells. The effect of oestradiol, 3a,5a-and 3b,5a-diols on MCF-7 cell proliferation was not seen in MDA-MB 231 cells.
Discussion
The results of this study clearly demonstrate that oestrogendependent human breast cancer cells efficiently biotransform androgens to A-ring tetrahydro-reduced metabolites, which possess the capability to transactivate oestrogen-regulated genes mediated by the a and b subtypes of hER. Indeed, MCF-7 cells incubated with radiolabelled androgens exhibited a large and rapid formation of tetrahydro-reduced metabolites, thus indicating a great activity of 5a-steroid reductases, types 1 and 2, and two enzymes of the aldo-keto reductases family, the 3a-hydroxysteroid dehydrogenase and the 3b-hydroxysteroid dehydrogenase. The large conversion of testosterone to 3a,5a-and 3b,5a-diols in MCF-7 cells had DHT as an obligatory intermediary as it was demonstrated by its inhibition induced by finasteride. This observation supports the concept that formation of diols from testosterone requires enzymemediated 5a-reduction (trans A/B ring junction) as the first metabolic step. In contrast, non-oestrogen-dependent MDA-MB 231 cells exhibited a limited bioconversion of androgens to 5a-reduced metabolites and very little, if any, formation of diols. An absence of bioconversion of androgen to diols was observed in HeLa and yeast cell incubations used as controls. The finding of an enhanced enzyme 5a-steroid reductase activity in MCF-7 cells, particularly in experiments carried out at pH 7$4, is in line with the report of Suzuki et al. (2001) , who have demonstrated an overexpression of the 5a-steroid reductase type-1 gene in human breast cancer tissues. Interestingly, our results revealed a selectively higher expression level of SRD5A1 in MCF-7 cells as compared with MDA-MB 231 cells, indicating a good agreement between enzyme expression levels and activities in human breast cancer cells. In contrast, no difference on the expression levels of AKR1C1 and AKR1C2 in MCF-7 and MDA-MB 231 cells was noticed. These results confirm and extend the report of Wiebe et al. (2000) , who, using radiolabelled progesterone as substrate, demonstrated an enhanced 5a-steroid reductase activity and also an overexpression of the 5a-steroid reductase type-1 gene in MCF-7 cells, as compared with oestrogen-resistant breast cells (MCF-10A). Furthermore, Wiebe & Lewis (2003) Steroid competitor (nM) Figure 7 Binding affinities of 3a,5a-and 3b,5a-androstanediols (diols) to human oestrogen receptors (hER). Cytosol aliquots of HeLa cells transfected with either hERa or hERb gene expression vectors were incubated with 1 nM [ 3 H] oestradiol at 4 8C, for 48 h, in the absence or presence of increasing concentrations of radioinert 3a,5a-diol, 3b,5a-diol and oestradiol (E 2 ). Bound and free steroid fractions were separated by the addition of dextran-coated charcoal. The 3b,5a-diol efficiently bound to both subtypes of hER, though with higher affinity for hERa. The 3a,5a-diol also bound to hERa and hERb, but only at the highest concentration used. E 2 , used as the control, was the most potent competitor for a and b subtypes of hER. Results represent the meanGS.D. of five experiments in triplicate.
lower expression levels of 3a-and 3b-hydroxysteroid dehydrogenase genes in breast cancer tissues as compared with paired breast normal tissue.
Another striking finding of this study was that 3a,5a-and 3b,5a-diols, the major metabolic conversion products of testosterone in MCF-7 cells, interact with relatively high binding affinity with both subtypes of hER and are capable of transactivating an oestrogen-dependent reporter gene (CAT) in the transiently co-transfected cell expression system employed, resembling the effects of naturally occurring oestradiol, though with lower potency. It must be underlined than even the formation of 3a,5a-diol from testosterone was almost double than that of its 3b-epimer, according to recrystallisation data, the 3b,5a-diol exhibited higher hERbinding affinity and higher oestrogen-like transactivation potency, as compared with its 3a-epimer, as shown in Fig. 8 and Table 2 . Further evidence that diols-induced gene transactivation in the construct assay is mediated via hREa and hERb, was derived from the observation that ICI-182 780 was able to preclude this effect. Our results confirm and extend previous reports on the activation of hERa by 3b,5a-diol. (Maggiolini et al. 1999 , García-Becerra et al. 2002 . These data are similar, though non-identical, with our previous observations with the tetrahydro-reduced metabolites of synthetic 19-nor progestins, which are also able to transactivate oestrogen-dependent genes mediated through hERa, but not through hERb, behaving as selective hER modulators (Lemus et al. 2000, Larrea et al. Figure 8 Oestrogen-like transactivation effects of androstanediols. Increasing concentrations of 3a,5a-androstanediol (3a,5a-diol), 3b,5a-androstanediol (3b,5a-diol) and oestradiol (E 2 ) were incubated with HeLa cells transiently co-transfected with expression vectors for hERa or hERb and an ERE-E1b-CAT reporter gene, for 24 h, at 37 8C. Results are expressed as percentage of CAT activity. Concentrations of 1!10 K8 M onwards of 3b,5a-Diol efficiently induced hERa-and hERb-mediated transactivation, in a similar manner to that of E 2 (A) and (C). 3a,5a-diol also induced hERaand hERb-mediated transactivation, yet with lower potency (B) and (D). Values are the meanGS.D. of five experiments performed in triplicate. For details see text. 1998, 2002) , the understanding of their binding mechanisms still awaits further studies. The study of enzyme gene expression disclosed that the large formation of diols in MCF-7 cells, with potent intrinsic oestrogen-agonistic effects at the genomic level, is the result of enhanced local activities of 5a-steroid reductases. This is mainly due to an overexpression of SRD5A1 and may have an important physiopathological significance, since these locally produced androgen metabolites are exerting their oestrogenlike intracrine effects in the same cells in which their synthesis take place, without significant diffusion into the circulation (Gingras et al. 1999 , Labrie et al. 2003 , Suzuki et al. 2005 . Although diols could be inactivated via glucuroconjugation, the enzymes responsible for this metabolic process (glucuronosyltransferases) have not been characterised in the human mammary gland (Labrie et al. 2003) . This observation is in line with the results of the present study, in which no watersoluble androgen metabolites were found. Furthermore, the role of 3b,5a-diol in breast cancer and other hormone-dependent neoplasias deserves further investigation because, in addition to its potent oestrogen-agonistic effects mediated via both subtypes of hER, its bioformation, in contrast to 3a,5a-diol, is virtually irreversible (Steckelbroeck et al. 2004 ). In addition, 3b,5a-diol may exert anti-proliferative and apoptotic effects in prostate epithelial cells through its interaction with hERb (Weihua et al. 2001 (Weihua et al. , 2002 . The preliminary results presented herein demonstrating that 3b,5a-diol and to a lesser extent its 3a-epimer are capable of inducing cell proliferation in cultured MCF-7 cells, in a similar manner to that of oestradiol, yet with lower potency, suggest the involvement of diols in breast cancer progression, however, further studies are required to have a better understanding on the role of diols in this malignancy. The on-going studies in our laboratories indicate that diols bind with low affinity to the human androgen receptor (hAR) and induce very limited hAR-mediated transactivation, particularly the 3a,5a-diol (A E Lemus, P Damian-Matsumura, R GarciaBecerra, L Gonzalez, D Orolaz, F Larrea & G Perez, Unpublished observations). The finasteride-induced inhibition of DHTand diols formation in MCF-7 cells, as demonstrated in this study, may have additional interest, since various locally formed A-ring-reduced metabolites of progesterone , Wiebe & Muzia 2001 , Wiebe & Lewis 2003 are capable of inducing cell proliferation in human breast cancer, through a novel, non-genomic mechanism (Weiler & Wiebe 2000) . The overall results demonstrated that finasteride inhibits the formation of oestrogenic steroids (diols) generated downstream of DHT, as suggested recently by Ishikawa et al. (2006) . In all, this study discloses a distinctive metabolic pathway of androgens in MCF-7 cells leading to a large formation of diols with oestrogen-agonistic activities, providing an insight into the controversial role of testosterone in human breast cancer. The data also demonstrated that pharmacological inhibition of 5a-steroid reductases precludes the bioconversion of androgens to non-phenolic metabolites with oestrogen-like effects, opening a new avenue of approach in breast cancer research and treatment. 
